Haas Cyrus M, Jasti Naveen, Dosey Annie, Allen Joel D, Gillespie Rebecca, McGowan Jackson, Leaf Elizabeth M, Crispin Max, DeForest Cole A, Kanekiyo Masaru, King Neil P
Department of Chemical Engineering, University of Washington, Seattle, WA 98195, USA.
Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
bioRxiv. 2025 Aug 20:2025.08.20.671178. doi: 10.1101/2025.08.20.671178.
Self-assembling protein nanoparticles are being increasingly utilized in the design of next-generation vaccines due to their ability to induce antibody responses of superior magnitude, breadth, and durability. Computational protein design offers a route to novel nanoparticle scaffolds with structural and biochemical features tailored to specific vaccine applications. Although strategies for designing new self-assembling proteins have been established, the recent development of powerful machine learning-based tools for protein structure prediction and design provides an opportunity to overcome several of their limitations. Here, we leveraged these tools to develop a generalizable method for designing novel self-assembling proteins starting from AlphaFold2 predictions of oligomeric protein building blocks. We used the method to generate six new 60-subunit protein nanoparticles with icosahedral symmetry, and single-particle cryo-electron microscopy reconstructions of three of them revealed that they were designed with atomic-level accuracy. To transform one of these nanoparticles into a functional immunogen, we reoriented its termini through circular permutation, added a genetically encoded oligomannose-type glycan, and displayed a stabilized trimeric variant of the influenza hemagglutinin receptor binding domain through a rigid linker. The resultant immunogen elicited potent receptor-blocking and neutralizing antibody responses in mice. Our results demonstrate the practical utility of machine learning-based protein modeling tools in the design of nanoparticle vaccines. More broadly, by eliminating the requirement for experimentally determined structures of protein building blocks, our method dramatically expands the number of starting points available for designing new self-assembling proteins.
自组装蛋白纳米颗粒因其能够诱导具有更高强度、广度和持久性的抗体反应,在下一代疫苗设计中得到越来越广泛的应用。计算蛋白设计为新型纳米颗粒支架提供了一条途径,其结构和生化特性可针对特定疫苗应用进行定制。尽管已经建立了设计新的自组装蛋白的策略,但基于机器学习的强大蛋白质结构预测和设计工具的最新发展提供了一个机会,可以克服其中的一些局限性。在这里,我们利用这些工具开发了一种通用方法,从寡聚蛋白构建块的AlphaFold2预测开始设计新型自组装蛋白。我们使用该方法生成了六种具有二十面体对称性的新的60亚基蛋白纳米颗粒,其中三种的单颗粒冷冻电子显微镜重建显示它们的设计具有原子水平的准确性。为了将其中一种纳米颗粒转化为功能性免疫原,我们通过环形排列重新定向其末端,添加了基因编码的寡甘露糖型聚糖,并通过刚性接头展示了流感血凝素受体结合域的稳定三聚体变体。所得免疫原在小鼠中引发了有效的受体阻断和中和抗体反应。我们的结果证明了基于机器学习的蛋白质建模工具在纳米颗粒疫苗设计中的实际效用。更广泛地说,通过消除对蛋白质构建块实验确定结构的要求,我们的方法极大地扩展了可用于设计新的自组装蛋白的起始点数量。